These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36372800)

  • 1. DOK7 CpG hypermethylation in blood leukocytes as an epigenetic biomarker for acquired tamoxifen resistant in breast cancer.
    Gowdini E; Aleyasin SA; Ramezani N; Nafisi N; Tutuni M
    J Hum Genet; 2023 Jan; 68(1):33-38. PubMed ID: 36372800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation of DNA-binding inhibitor 4 serves as a potential biomarker in distinguishing acquired tamoxifen-refractory breast cancer.
    Zhang Y; Zhang B; Fang J; Cao X
    Int J Clin Exp Pathol; 2015; 8(8):9500-5. PubMed ID: 26464711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker.
    Heyn H; Carmona FJ; Gomez A; Ferreira HJ; Bell JT; Sayols S; Ward K; Stefansson OA; Moran S; Sandoval J; Eyfjord JE; Spector TD; Esteller M
    Carcinogenesis; 2013 Jan; 34(1):102-8. PubMed ID: 23054610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.
    Martens JW; Nimmrich I; Koenig T; Look MP; Harbeck N; Model F; Kluth A; Bolt-de Vries J; Sieuwerts AM; Portengen H; Meijer-Van Gelder ME; Piepenbrock C; Olek A; Höfler H; Kiechle M; Klijn JG; Schmitt M; Maier S; Foekens JA
    Cancer Res; 2005 May; 65(10):4101-17. PubMed ID: 15899800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene.
    Chang HG; Kim SJ; Chung KW; Noh DY; Kwon Y; Lee ES; Kang HS
    J Mol Med (Berl); 2005 Feb; 83(2):132-9. PubMed ID: 15536519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenteic Alteration of
    Moradi A; Aleyasin SA; Mohammadian K; Alizamir A
    Iran J Biotechnol; 2022 Apr; 20(2):e3050. PubMed ID: 36337064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
    Palomeras S; Diaz-Lagares Á; Viñas G; Setien F; Ferreira HJ; Oliveras G; Crujeiras AB; Hernández A; Lum DH; Welm AL; Esteller M; Puig T
    Breast Cancer Res; 2019 Jul; 21(1):79. PubMed ID: 31277676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of methylation changes of
    Shirkavand A; Boroujeni ZN; Aleyasin SA
    Indian J Cancer; 2018; 55(4):366-371. PubMed ID: 30829272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
    Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
    Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives.
    Sukocheva OA; Lukina E; Friedemann M; Menschikowski M; Hagelgans A; Aliev G
    Semin Cancer Biol; 2022 Jul; 82():35-59. PubMed ID: 33301860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy.
    Fan Y; Xie G; Wang Z; Wang Y; Wang Y; Zheng H; Zhong X
    Breast Cancer Res Treat; 2022 Feb; 192(1):33-42. PubMed ID: 34978016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death.
    Hwang S; Park S; Kim JH; Bang SB; Kim HJ; Ka NL; Ko Y; Kim SS; Lim GY; Lee S; Shin YK; Park SY; Kim S; Lee MO
    Life Sci; 2023 Sep; 328():121827. PubMed ID: 37276910
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Martín-Sánchez E; Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Córdoba A; Vicente-García F; Blanco-Luquin I; De La Cruz S; Aramendia A; Guerrero-Setas D
    Clin Epigenetics; 2017; 9():7. PubMed ID: 28149335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 promoter hypermethylation signature for early detection of breast cancer in the Vietnamese population.
    Truong PK; Lao TD; Doan TP; Le TA
    Asian Pac J Cancer Prev; 2014; 15(22):9607-10. PubMed ID: 25520075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Zendehbad Z; Tavakkoly-Bazzaz J
    J Cell Biochem; 2019 Aug; 120(8):12393-12401. PubMed ID: 30816620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors.
    Fitzgerald LM; Browne EP; Christie KD; Punska EC; Simmons LO; Williams KE; Pentecost BT; M Jawale R; Otis CN; Arcaro KF
    Cancer Cell Int; 2016; 16():8. PubMed ID: 26884724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating FGFR2 gene as a blood-based epigenetic biomarker in gastric cancer.
    Aleyasin SA; Moradi A; Abolhasani N; Abdollahi M
    Mol Biol Rep; 2024 Feb; 51(1):253. PubMed ID: 38302798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.